The chart above plots the price of CHRD over the range selected — one day to the full history — drawn by TradingView from their own data. Our own licensed end-of-day series holds 66 sessions over that window: $149.00 on 4 May 2026 through $140.42 on 31 July 2026. Finazon · prior-day close.
Market cap$7.9B
P/E (TTM)133.7
52-week range$85.00 – $150.00
Avg volume217.5K
Finazon · prior-day close · valuation computed from SEC EDGAR filings · as of Aug 2, 2026
CHRD insider trades
SEC Form 4 · last 90 days · newest reported trade 23 Jul 2026
Open-market buys0
Open-market sells5
Net sold$2.69M
Non-trade filings1
DateInsiderTypeSharesValue
23 Jul 2026Lou Michael HEVP, CSO, and CCOSell10,000$1.40M
15 May 2026Henke Darrin J.EVP and COOSell1,276$186K
11 May 2026Brooks Douglas EDirectorSell1,500$208K
08 May 2026Brooks Douglas EDirectorSell3,500$478K
07 May 2026Brooks Douglas EDirectorSell3,000$413K
Compensation mechanics
Share grants, option exercises, tax withholding and transfers. They reach the same Form 4 as a trade, but they are not the insider buying or selling on the open market, so no purchase or sale value applies to them.
DateInsiderTypeSharesValue
15 Jun 2026Dundas Ian CDirectorGift72,171
CHRD reported financials
SEC EDGAR XBRL
CHRD reported revenue of $4.9B for the fiscal year ended 31 Dec 2025. Net income over the same period was $44.5M.
FigureReportedPeriod
Revenue
$4.9B
31 Dec 2025 fiscal year
Net income
$44.5M
31 Dec 2025 fiscal year
Diluted EPS
$0.74
31 Dec 2025 fiscal year
Total assets
$13.2B
31 Mar 2026 at period end
Total equity
$8.0B
31 Mar 2026 at period end
Source: SEC EDGAR XBRL company facts · latest period ended 31 Mar 2026
CHRD earnings
SEC EDGAR
DatePeriodEPSRevenue
31 Mar 2026Q1 2026$1.90—
31 Dec 2025FY 2025$0.74—
30 Sep 2025Q3 2025$2.26—
30 Jun 2025Q2 2025$-6.77—
31 Mar 2025Q1 2025$3.66—
31 Dec 2024FY 2024$16.02—
30 Sep 2024Q3 2024$3.59—
30 Jun 2024Q2 2024$4.25—
Reported figures & scheduled dates · SEC EDGAR filings
CHRD institutional holders
SEC Form 13F
8 of the 45 institutional funds we track reported a CHRD position for the quarter ended 31 Mar 2026 — a combined $214.9M; the latest of those filings landed 15 May 2026.